Day 1 :
Kingston University, UK
Keynote: Pharmacy education in the UK and potential partnership opportunities with Universities in the Middle East
Time : 9:30-10:15
Professor Raid Alany is a registered New Zealand Pharmacist with a PhD from the University of Otago, Dunedin, New Zealand. He is the Inaugural Head of School of Life Sciences, Pharmacy and Chemistry at Kingston University London, UK; holds an honorary professorship at the University of Auckland, New Zealand. He is the Editor-in-Chief of Pharmaceutical Development and Technology (Taylor and Francis) and Immediate Past President of the New Zealand Chapter of the Controlled Release Society. Raid’s research is on ophthalmic drug delivery, lipid and surfactant-based systems, in-situ gels and animal health. He holds international patents that have been commercialized in New Zealand and Australia where he consults for animal health companies, regulatory bodies and IP-specialized law firms. His research gate score is 35.72 and his h-index is 21 (google scholar).
Currently, there are 26 UK-based universities that offer the Master of Pharmacy (MPharm) degree which is one of the main requirements to practice pharmacy in the UK. To register as a pharmacist in the UK, one must successfully complete a GPhC accredited (MPharm) course, which is a full-time, four-year course followed by successful completion of one year's pre-registration training, a period of paid employment in a community or hospital pharmacy during which a trainee is required to build up a portfolio of evidence and demonstrate their competence whilst being observed at work. This is followed by successful completion of the GPhC's registration exam along with meeting the fitness to practice requirements for registration as a pharmacist. On the other hand; courses in pharmaceutical sciences (BSc and MSc) throughout the UK are aimed at training graduates and preparing them to work in the pharmaceutical industry or specialize in regulatory affairs or clinical trials.
Universities in the UK are reaching out to universities around the world to establish partnerships for joint provision. Such partnerships could come in various shapes and forms. The QAA UK Quality Code defines collaborative provision as ‘learning opportunities leading or contributing to the award of academic credit or a qualification that are delivered, assessed or supported through an arrangement with one or more organizations other than the degree-awarding body’. Validation, franchise, dual degree, double degree, joint degree, articulation and placements are terms that are used in this context and could be rather confusing.
This key note will cover the key aspects of pharmacy / pharmaceutical sciences education in the UK. This will be followed by an explanation of the various forms of joint academic provision that are already in place and are available to pursue by universities in the Middle East should they wish to partner with a UK-based university.
Dubai Pharmacy College, UAE
Keynote: Nanotechnology Applications
Time : 10:15-11:00
Prof. Heyam Saad Ali has completed her PhD from Bradford University, UK. She is working as a head of pharmaceutics department, head of quality assurance and auditing unit of Dubai Pharmacy college, UAE, since 2000.She has teaching and research experience of about 25 years. She is a member of various pharmaceutical associations. She contributed more than 50 articles to reputed international scientific journals in different controlled and targeted drug delivery systems. She has been invited as speaker to numerous International conferences .She is reviewer and member of editorial board of many international pharmaceutical journals.
Nanotechnology is the study of extremely small structures. It can be used for a broad range of applications and the creation of various types of nano materials, nano devices, and nano- systems, due to their unique properties. This presentation will include: different manufacturing approaches, aspects and scope of nanotechnology. The advancement of nanotechnology and its applications to in the field of medicines and pharmaceuticals in different areas has revolutionized the twentieth century. Pharmaceutical Applications of nano particles in drug delivery and protein and peptide delivery, has impact in drug development, bioavailability, stability. Clinical Applications of nanotechnology in various nano systems in cancer therapy such as carbon nano tube, dendrimers, nano crystal, nano wire, nano shells etc and in operative dentistry, ophthalmology, surgery, visualization, tissue engineering, antibiotic resistance, immune response and the treatment of neuro degenerative disorders, tuberculosis, and Parkinson’s disease and Alzheimer’s disease.